Newer fluoroquinolones in the treatment of acute exacerbations of COPD

References

• AdamsSGMeloJLutherM2000Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPDChest11713455210807821
   PubMed Web of Science ®Google Scholar
• AllegraLBlasiFde BernardiB2001Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis:a re-evaluation of previously published data of a placebo-controlled randomised studyPulm Pharmacol Ther141495511273797
   PubMed Web of Science ®Google Scholar
• AnderssonFBorgSJanssonSA2002The costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med96700812243316
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPW1987Antibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med1061962043492164
   PubMed Web of Science ®Google Scholar
• BalfourJABWisemanLR1999MoxifloxacinDrugs573637310193688
   PubMed Web of Science ®Google Scholar
• BalterMSLa ForgeJLowDE2003Canadian guidelines for the management of acute exacerbations of chronic bronchitisCan Respir J10Suppl B332B
   PubMedGoogle Scholar
• BanerjeeDKhairOAHoneybourneD2004Impact of sputum bacteria on airway inflammation and health status in clinical stable COPDEur Respir J236859115176680
   PubMed Web of Science ®Google Scholar
• British Thoracic Society (BTS)2004Chronic Obstructive Pulmonary Disease. National Clinical Guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary careThorax59Suppl 11232
   Google Scholar
• CelliBRMacneeWAnzuetoA2004Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease:a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• De PontiFPoluzziEMontanaroN2000QT-interval prolongation by non-cardiac drugs:lessons to be learned from recent experienceEur J Clin Pharmacol5611810853872
   PubMed Web of Science ®Google Scholar
• DestacheCJDewanNO’DonohueWJ1999Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitisJ Antimicrob Chemother43Suppl A1071310225580
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelIS2003Longitudinal changes in the nature, severity and frequency of chronic obstructive pulmonary disease exacerbationsEur Respir J22931614680081
   PubMed Web of Science ®Google Scholar
• FogartyR1999Efficacy and safety of moxifloxacin versus clarithromycin for community aquired pneumoniaInfect Med1674863
   Web of Science ®Google Scholar
• GumpDWPhillipsCAForsythBR1976Role of infection in chronic bronchitisAm Rev Respir Dis113465741267252
   PubMed Web of Science ®Google Scholar
• HillATCampbellEJHillSL2000Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitisAm J Med1092889510996579
   PubMed Web of Science ®Google Scholar
• JonesMeSahmDFMartinN2000Prevalence of gyrA, gyrB, parC and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluorquinolones and originating from worldwide surveillance studies during the 1997–1998 respiratory seasonAntimicrob Agents Chemother44462610639387
   PubMed Web of Science ®Google Scholar
• KannerRAnthonisenNRConnettJE2001Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease:results from the lung health study. The Lung Health Study Research GroupAm J Respir Crit Care Med1643586411500333
   PubMed Web of Science ®Google Scholar
• LodeHEllerJLinnhoffA2004Levofloxacin versus clarithromycin in chronic obstructive pulmonary disease exacerbation:focus on exacerbation-free intervalEur Respir J249475315572537
   PubMed Web of Science ®Google Scholar
• LopezADMurrayCC1998The global burden of disease, 1990–2020Nat Med4124139809543
   PubMed Web of Science ®Google Scholar
• MonsoERuizJRosellA1995Bacterial infection in chronic obstructive airways disease:a study of stable and exacerbated patients using the protected specimen brushAm J Respir Crit Care Med1521316207551388
   PubMed Web of Science ®Google Scholar
• MonsoERosellABonetG1999Risk factors for lower airway bacterial colonisation in chronic bronchitisEur Respir J133384210065678
   PubMed Web of Science ®Google Scholar
• MurphyTFSethiS1992Bacterial infection in chronic obstructive pulmonary diseaseAm Rev Respir Dis1461067831416398
   PubMed Web of Science ®Google Scholar
• NouiraSMarghliSBelghithM2001Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation:a randomised placebo-controlled trialLancet3582020511755608
   PubMed Web of Science ®Google Scholar
• ObajiASethiS2001Acute exacerbations of chronic bronchitis. What role for the new fluoroquinolones?Drugs and Aging1811111232735
   PubMed Web of Science ®Google Scholar
• Park-WyllieLYJuurlinkDNKoppN2006Outpatient gatifloxacin therapy and dysglycaemia in older adultsN Engl J Med35413526116510739
   PubMed Web of Science ®Google Scholar
• PatelISSeemungalTAWilksM2002Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbationsThorax577596412200518
   PubMed Web of Science ®Google Scholar
• PerryCMBalfourJABLambH1999GatifloxacinDrugs586839610551438
   PubMed Web of Science ®Google Scholar
• PrescottELangePVestboJ1995Chronic mucus hypersecretion in COPD and death from pulmonary infectionEur Respir J8133387489800
   PubMed Web of Science ®Google Scholar
• RobertsCMLoweDBucknellCE2002Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary diseaseThorax571374111828043
   PubMed Web of Science ®Google Scholar
• SaintSKBentSVittinghoffE1995Antibiotics in chronic obstructive pulmonary disease exacerbations:a meta-analysisJAMA273957607884956
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SeemungalTHarper-OwenRBhowmikA2001Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16416182311719299
   PubMed Web of Science ®Google Scholar
• SethiSEvansNGrantB2002New strains of bacteria and exacerbations of chronic obstructive pulmonary diseaseN Engl J Med3474657112181400
   PubMed Web of Science ®Google Scholar
• SethiSWronaCGrantBJB2004Strain-specific immune response to Haemophilus influenza in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1694485314597486
   PubMed Web of Science ®Google Scholar
• SethiS2005Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseCID41S17785
   PubMed Web of Science ®Google Scholar
• SethiSMaloneyJGroveL2006Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary diseaseAm J Resp Crit Care Med173991816474030
   PubMed Web of Science ®Google Scholar
• SherillDLLebowitzMDBurrowsB1990Epidemiology of chronic obstructive pulmonary diseaseClin Chest Med11375872205437
   PubMed Web of Science ®Google Scholar
• SolerNEwigSTorresA1999Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive diseaseEur Respir J1410152210596683
   PubMed Web of Science ®Google Scholar
• VestboJPrescottELangePThe Copenhagen City Heart Study Group1996Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidityAm J Respir Crit Care Med153153058630597
   PubMed Web of Science ®Google Scholar
• WedzichaJ2001Airway infection accelerates decline of lung function in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1641757811734418
   PubMed Web of Science ®Google Scholar
• WhiteAJGompertzSBayleyDL2003Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisThorax586808512885984
   PubMed Web of Science ®Google Scholar
• WilsonRDowlingRBJacksonAD1996The biology of bacterial colonisation and invasion of the respiratory mucosaEur Respir J91523308836669
   PubMed Web of Science ®Google Scholar
• WilsonRKubinRBallinI1999Five day moxifloxacin therapy compared with seven day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitisJ Antimicrob Chemother445011310588312
   PubMed Web of Science ®Google Scholar
• WilsonR2001Bacteria, antibiotics and COPDEur Respir J17995100711488337
   PubMed Web of Science ®Google Scholar
• WilsonRSchentaggJJBallP2002Comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomesClin Therap246395212017408
   PubMed Web of Science ®Google Scholar
• WilsonRAllegraLHuchonG2004Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitisChest1259536415006954
   PubMed Web of Science ®Google Scholar
• WilsonR2005Treatment of COPD exacerbations:antibioticsEur Respir Rev14328
   Google Scholar
• WilsonRJonesPSchabergT2006Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitisThorax613374216449273
   PubMed Web of Science ®Google Scholar
• ZalacainRSobradilloVAmilibiaJ1999Predisposing factors to bacterial colonisation in chronic obstructive pulmonary diseaseEur Respir J13343810065679
   PubMed Web of Science ®Google Scholar